HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

H Joachim Deeg Selected Research

Refractory Anemia with Excess of Blasts (RAEM)

1/2008Gene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in disease initiation and progression.
12/2005NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).
1/2005Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.
12/2004Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML.
11/2004Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


H Joachim Deeg Research Topics

Disease

59Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2015 - 01/2002
41Graft vs Host Disease (Graft-Versus-Host Disease)
12/2014 - 01/2002
17Primary Myelofibrosis (Myelosclerosis)
11/2015 - 07/2002
15Neoplasms (Cancer)
01/2015 - 07/2002
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2015 - 01/2002
11Aplastic Anemia (Anemia, Hypoplastic)
12/2014 - 07/2005
10Leukemia
11/2015 - 01/2003
9Hematologic Neoplasms (Hematological Malignancy)
04/2013 - 05/2005
6Polycythemia Vera
11/2015 - 07/2002
6Essential Thrombocythemia
11/2015 - 07/2002
5Iron Overload
08/2013 - 11/2008
5Refractory Anemia with Excess of Blasts (RAEM)
01/2008 - 11/2004
5Myeloproliferative Disorders (Myeloproliferative Disorder)
11/2006 - 08/2002
4Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
07/2013 - 09/2005
4Chromosome Aberrations (Chromosome Abnormalities)
08/2012 - 08/2004
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2012 - 03/2011
3Necrosis
06/2010 - 07/2002
3Anemia
10/2009 - 01/2008
2Fanconi Anemia (Fanconi's Anemia)
10/2015 - 09/2004
2Thrombocytopenia (Thrombopenia)
01/2015 - 01/2011
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2010 - 08/2003
2Basal Cell Carcinoma (Rodent Ulcer)
02/2009 - 03/2006
2Liver Failure
08/2008 - 03/2004
2Renal Insufficiency (Renal Failure)
05/2008 - 10/2003
2Fibrosis (Cirrhosis)
03/2007 - 01/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2006 - 05/2005
2Refractory Anemia
12/2005 - 11/2004
1Anoxia (Hypoxia)
09/2015
1Residual Neoplasm
02/2015
1Systemic Mastocytosis
10/2014
1Acute-Phase Reaction
06/2014
1Emphysema
06/2014
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
08/2013
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
07/2013
1Splenomegaly
09/2012
1Rheumatoid Arthritis
06/2010
1Multiple Sclerosis
06/2010
1Leukocytosis (Pleocytosis)
09/2009
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2009
1Infection
03/2009

Drug/Important Bio-Agent (IBA)

8Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015 - 08/2002
7Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2010 - 07/2002
6Methotrexate (Mexate)FDA LinkGeneric
12/2014 - 08/2003
6Busulfan (Busulfex)FDA Link
07/2013 - 01/2002
6AntigensIBA
09/2012 - 05/2003
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2010 - 09/2004
5Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2012 - 11/2004
4lenalidomide (CC 5013)FDA Link
03/2013 - 01/2008
4fludarabineIBA
07/2012 - 12/2009
4IronIBA
01/2011 - 02/2009
3Proteins (Proteins, Gene)IBA
05/2015 - 12/2005
3GlucocorticoidsIBA
01/2014 - 05/2007
3Azacitidine (5 Azacytidine)FDA Link
09/2012 - 03/2010
3TNFR-Fc fusion protein (etanercept)FDA Link
06/2010 - 11/2004
3Prednisone (Sone)FDA LinkGeneric
09/2009 - 07/2002
2Phosphotransferases (Kinase)IBA
11/2015 - 09/2014
2Tacrolimus (Prograf)FDA LinkGeneric
12/2014 - 05/2008
2Histones (Histone)IBA
01/2014 - 01/2008
2Biological Markers (Surrogate Marker)IBA
10/2012 - 10/2009
2thymoglobulinIBA
01/2012 - 05/2006
2CalcineurinIBA
08/2011 - 05/2008
2mycophenolate mofetil (Cellcept)FDA LinkGeneric
08/2011 - 07/2005
2Ferritins (Ferritin)IBA
10/2009 - 11/2008
2TNF-Related Apoptosis-Inducing LigandIBA
12/2008 - 09/2004
2Transferrin (beta 2 Transferrin)IBA
08/2008 - 03/2004
2Caspase 8 (Caspase-8)IBA
09/2004 - 08/2003
1eltrombopagFDA Link
01/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2014
1alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA
06/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
15q- syndromeIBA
07/2013
1MicroRNAs (MicroRNA)IBA
03/2013
1Transcription Factors (Transcription Factor)IBA
03/2013
1ProteomeIBA
10/2012
1Hemoglobins (Hemoglobin)IBA
03/2012
1fludarabine monophosphate (Fludara)FDA LinkGeneric
01/2012
1treosulfanIBA
03/2011
1decitabine (5-aza-2'-deoxycytidine)FDA Link
01/2011
1CytokinesIBA
01/2011
1deferasiroxFDA Link
01/2011
1HLA-DR15IBA
12/2010
1Twist Transcription FactorIBA
09/2010
1Carbon MonoxideIBA
06/2010
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2010
1tebufenozide (Mimic)IBA
10/2009
1Thalidomide (Thalomid)FDA Link
09/2009
1pomalidomideIBA
09/2009

Therapy/Procedure

66Cell Transplantation
11/2015 - 05/2003
31Transplantation (Transplant Recipients)
11/2013 - 01/2002
30Transplants (Transplant)
09/2015 - 01/2002
18Hematopoietic Stem Cell Transplantation
05/2015 - 01/2002
8Stem Cell Transplantation
05/2015 - 07/2002
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2012 - 03/2002
4Homologous Transplantation (Allograft)
02/2015 - 07/2005
4Drug Therapy (Chemotherapy)
02/2015 - 01/2005
2Artificial Respiration (Mechanical Ventilation)
09/2015 - 10/2003
2Erythrocyte Transfusion
10/2009 - 11/2008
1Heterologous Transplantation (Xenotransplantation)
01/2014
1Splenectomy
09/2012
1Aftercare (After-Treatment)
03/2011